Clinical trial
Phase II Trial of Pemetrexed for Advanced Chondrosarcomas
NCT00107419 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Trial of Pemetrexed for Advanced Chondrosarcomas
- Lead sponsor
- SWOG Cancer Research Network
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2005
- Completion date
- August 31, 2009
- Enrollment
- 75 (actual)
- Sites
- 58
Conditions
As the registry lists them; a condition with its own page is linked.